M&A Deal Summary |
|
|---|---|
| Date | 2009-09-08 |
| Target | Surendra Genetic Labs Pvt. |
| Sector | Medical Products |
| Buyer(s) | Revvity |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1937 |
| Sector | Medical Products |
| Employees | 11,000 |
| Revenue | 2.8B USD (2024) |
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity was formed in 1937 and is based in Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 14 of 37 |
| Sector: Medical Products M&A | 5 of 11 |
| Type: Add-on Acquisition M&A Deals | 12 of 35 |
| Country: India M&A | 1 of 2 |
| Year: 2009 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-09-08 |
Shanghai Sym-Bio LifeScience Co.
Shanghai, China SYM-BIO Lifescience is a high quality, innovative diagnostic products. The company's offerings include optical mechanical technology, electrical automation, chemical synthesis, and cloned antibodies preparation. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-04-15 |
Signature Genomic Laboratories
Spokane, Washington, United States Signature Genomic Laboratories, LLC is a provider of microarray-based cytogenetic diagnostics with its proprietary SignatureChip and is the major in providing microarray-based chromosome analysis. |
Buy | - |
